With a strong clinical-stage pipeline, Agenus harnesses a combination of proprietary antibody platforms, for example Retrocyte Show™ and SECANT®, and progressive mobile therapy strategies, positioning itself for a important contributor inside the biotechnology and immunotherapy arena.Our investment management company generates asset-primarily ba